Covid-19: Refuerzo de Pfizer contra Omicron podría autorizarse esta semana

Pfizer’s new Covid-19 vaccine booster targeting the omicron BA.4 and BA.5 variants could get FDA authorization as early as this week.

Fuente: Youtube